Sign Up Today and Learn More About Atrandi Biosciences Stock
Invest in or calculate the value of your shares in Atrandi Biosciences or other pre-IPO companies through EquityZen's platform.
Atrandi Biosciences Stock (ATRB)
Atrandi Biosciences is a Lithuanian biotech startup that aims to commercialize droplet microfluidics technology.
About Atrandi Biosciences Stock
Founded
2016
Industries
Science and Engineering, Health Care, Biotechnology
Atrandi Biosciences Press Mentions
Stay in the know about the latest news on Atrandi Biosciences
Financings for Feb. 20, 2025
bioworld • Feb 21, 2025
Atrandi Raises $25M to Develop New Products Based on Semi-Permeable Capsule Tech
genengnews • Feb 21, 2025
Atrandi Biosciences Raises $25M in Series A Funding
finsmes • Feb 20, 2025
Lithuanian biotech company secures $25M to expand single-cell research in the US
arcticstartup • Feb 19, 2025
Lithuanian company Atrandi Biosciences raises $25M in Series A funding
en • Feb 19, 2025
Atrandi Biosciences Management
Leadership team at Atrandi Biosciences
Chief Technology Officer
Karolis Leonavicius
Chief Scientific Officer
Rapolas Zilionis
Join now and verify your accreditation status to gain access to:
- Atrandi Biosciences Current Valuation
- Atrandi Biosciences Stock Price
- Atrandi Biosciences Management
- Available deals in Atrandi Biosciences and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Atrandi Biosciences Cap Table and Funding History by Share Class and Liquidity Preferences
- Atrandi Biosciences Revenue and Financials
- Atrandi Biosciences Highlights
- Atrandi Biosciences Business Model
- Atrandi Biosciences Risk Factors
- Atrandi Biosciences Research Report from SACRA Research
Trading Atrandi Biosciences Stock
How to invest in Atrandi Biosciences stock?
Accredited investors can buy pre-IPO stock in companies like Atrandi Biosciences through EquityZen funds. These investments are made available by existing Atrandi Biosciences shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Atrandi Biosciences stock?
Shareholders can sell their Atrandi Biosciences stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
